VPIM
RANI icon

Vanguard Personalized Indexing Management’s Rani Therapeutics RANI Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,396
Closed -$7.91K – 2045
2025
Q2 		$7.91K Sell
15,396
-5,043
-25% -$4.12K ﹤0.01% 1935
2025
Q1 		$25.8K Buy
+20,439
New +$30.2K ﹤0.01% 1746

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Vanguard Personalized Indexing Management's RANI Position: Q3 2025 in Review

Vanguard Personalized Indexing Management sold out of Rani Therapeutics (RANI) in Q3 2025, closing a stake of 15,396 shares — an estimated $7.91K sold.

Vanguard Personalized Indexing Management first reported a position in RANI in Q1 2025 and held it in 2 quarters. The position peaked at $25.8K in Q1 2025. 38 funds tracked by Wall St. Rank hold RANI as of Q3 2025.

  • Vanguard Personalized Indexing Management reported no remaining Rani Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 15,396 Rani Therapeutics shares in Q3 2025, an estimated $7.91K.
  • Vanguard Personalized Indexing Management first reported a position in Rani Therapeutics in Q1 2025 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Rani Therapeutics position peaked at $25.8K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2025, filed 31 Oct 2025.